Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Srisuda, Keayarsa"'
Autor:
Viravarn Luvira, William H. K. Schilling, Podjanee Jittamala, James A. Watson, Simon Boyd, Tanaya Siripoon, Thundon Ngamprasertchai, Pedro J. Almeida, Maneerat Ekkapongpisit, Cintia Cruz, James J. Callery, Shivani Singh, Runch Tuntipaiboontana, Varaporn Kruabkontho, Thatsanun Ngernseng, Jaruwan Tubprasert, Mohammad Yazid Abdad, Srisuda Keayarsa, Wanassanan Madmanee, Renato S. Aguiar, Franciele M. Santos, Pongtorn Hanboonkunupakarn, Borimas Hanboonkunupakarn, Kittiyod Poovorawan, Mallika Imwong, Walter R. J. Taylor, Vasin Chotivanich, Kesinee Chotivanich, Sasithon Pukrittayakamee, Arjen M. Dondorp, Nicholas P. J. Day, Mauro M. Teixeira, Watcharapong Piyaphanee, Weerapong Phumratanaprapin, Nicholas J. White, the PLATCOV Collaborative Group
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Brief summary In early symptomatic COVID-19 treatment, high dose oral favipiravir did not accelerate viral clearance. Background Favipiravir, an anti-influenza drug, has in vitro antiviral activity against SARS-CoV-2. Clinical trial evidence
Externí odkaz:
https://doaj.org/article/38be8586c0b14f9a9e31989e8009d6df
Autor:
Viravarn Luvira, William HK Schilling, Podjanee Jittamala, James A Watson, Simon Boyd, Tanaya Siripoon, Thundon Ngamprasertchai, Pedro J Almeida, Maneerat Ekkapongpisit, Cintia Cruz, James J Callery, Shivani Singh, Runch Tuntipaiboontana, Varaporn Kruabkontho, Thatsanun Ngernseng, Jaruwan Tubprasert, Mohammad Yazid Abdad, Srisuda Keayarsa, Wanassanan Madmanee, Renato S Aguiar, Franciele M Santos, Pongtorn Hanboonkunupakarn, Borimas Hanboonkunupakarn, Kittiyod Poovorawan, Mallika Imwong, Walter RJ Taylor, Vasin Chotivanich, Kesinee Chotivanich, Sasithon Pukrittayakamee, Arjen M Dondorp, Nicholas PJ Day, Mauro M Teixeira, Watcharapong Piyaphanee, Weerapong Phumratanaprapin, Nicholas J White
Background: Favipiravir, an anti-influenza drug, has in vitro antiviral activity against SARS-CoV-2. Clinical trial evidence to date is inconclusive. Favipiravir has been recommended for the treatment of COVID-19 in some countries. Methods: In a mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::294a2d4e7c36d7423163dd0cc3a11e68
https://doi.org/10.21203/rs.3.rs-2675703/v1
https://doi.org/10.21203/rs.3.rs-2675703/v1
Autor:
Podjanee Jittamala, William HK Schilling, James A Watson, Viravarn Luvira, Tanaya Siripoon, Thundon Ngamprasertchai, Pedro J Almeida, Maneerat Ekkapongpisit, Cintia Cruz, James J Callery, Simon Boyd, Orawan Anunsittichai, Maliwan Hongsuwan, Yutatirat Singhaboot, Watcharee Pagornrat, Runch Tuntipaiboontana, Varaporn Kruabkontho, Thatsanun Ngernseng, Jaruwan Tubprasert, Mohammad Yazid Abdad, Srisuda Keayarsa, Wanassanan Madmanee, Renato S Aguiar, Franciele M Santos, Elizabeth M Batty, Pongtorn Hanboonkunupakarn, Borimas Hanboonkunupakarn, Sakol Sookprome, Kittiyod Poovorawan, Mallika Imwong, Walter RJ Taylor, Vasin Chotivanich, Chunlanee Sangketchon, Wiroj Ruksakul, Kesinee Chotivanich, Sasithon Pukrittayakamee, Arjen M Dondorp, Nicholas PJ Day, Mauro M Teixeira, Watcharapong Piyaphanee, Weerapong Phumratanaprapin, Nicholas J White
BackgroundUncertainty over the therapeutic benefit provided by parenteral remdesivir in COVID-19 has resulted in varying treatment guidelines. Early in the pandemic the monoclonal antibody cocktail, casirivimab/imdevimab, proved highly effective in c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f8b4bebb105cc4d47dea7ba7b07e50e
https://doi.org/10.1101/2022.10.17.22281161
https://doi.org/10.1101/2022.10.17.22281161
Autor:
Somporn Saiwaew, Juntima Sritabal, Nattaporn Piaraksa, Srisuda Keayarsa, Ronnatrai Ruengweerayut, Chirapong Utaisin, Patima Sila, Rangsan Niramis, Rachanee Udomsangpetch, Prakaykaew Charunwatthana, Emsri Pongponratn, Sasithon Pukrittayakamee, Anna M Leitgeb, Mats Wahlgren, Sue J Lee, Nicholas P J Day, Nicholas J White, Arjen M Dondorp, Kesinee Chotivanich
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0172718 (2017)
In severe falciparum malaria cytoadherence of parasitised red blood cells (PRBCs) to vascular endothelium (causing sequestration) and to uninfected red cells (causing rosette formation) contribute to microcirculatory flow obstruction in vital organs.
Externí odkaz:
https://doaj.org/article/b9f7e3432df34c2786d285c76a5cb363
Autor:
Weerapong Phumratanaprapin, Kesinee Chotivanich, Parinya Kunawut, Arjen M. Dondorp, Yutatirat Singhaboot, Srisuda Keayarsa, Nattaporn Piaraksa
Plasmodium falciparum infection causes febrile illness and severe disease with multiple organ failure and death when treatment is delayed. Antipyretic treatment is standard, and inducing hypothermia has been proposed to protect the brain in cerebral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee214ea584a6f2a38b44a7dbabbd1676
https://ora.ox.ac.uk/objects/uuid:93d27c01-f90e-4c5a-8302-99ccbecc5a97
https://ora.ox.ac.uk/objects/uuid:93d27c01-f90e-4c5a-8302-99ccbecc5a97
Autor:
Yutatirat, Singhaboot, Srisuda, Keayarsa, Nattaporn, Piaraksa, Weerapong, Phumratanaprapin, Parinya, Kunawut, Arjen, Dondorp, Kesinee, Chotivanich
Publikováno v:
The American journal of tropical medicine and hygiene. 100(5)
Autor:
Juntima Sritabal, Srisuda Keayarsa, Nattaporn Piaraksa, Arjen M. Dondorp, Rachanee Udomsangpetch, Chirapong Utaisin, Nicholas P. J. Day, Patima Sila, Kesinee Chotivanich, Prakaykaew Charunwatthana, Somporn Saiwaew, Nicholas J. White, Ronnatrai Ruengweerayut, Sue J. Lee, Anna Leitgeb, Rangsan Niramis, Emsri Pongponratn, Mats Wahlgren, Sasithon Pukrittayakamee
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0172718 (2017)
PLoS ONE
PLoS ONE
In severe falciparum malaria cytoadherence of parasitised red blood cells (PRBCs) to vascular endothelium (causing sequestration) and to uninfected red cells (causing rosette formation) contribute to microcirculatory flow obstruction in vital organs.